Peripheral Nerve Stimulation in Patients Undergoing Arteriovenous Fistula Creation

Overview

About this study

The purpose of this study is to study the analgesic efficacy of peripheral nerve stimulation with SPR Therapeutics, Inc. (Cleveland, OH) lead in reducing opioid usage in patients undergoing arteriovenous fistula creation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

> 18 years of age, need for hemodialysis.

Exclusion Criteria:

Previous fistulas, central vein occlusion, ipsilateral upper extremity deep vein occlusion, ipsilateral brachial or radial artery stenosis or calcification, coagulopathy, and/or infection at the operative site.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 3/04/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Houssam Farres, M.D.	Open for enrollment	Contact information: Clinical Studies Unit (904) 953-2255

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Houssam Farres, M.D.

Open for enrollment

Contact information:

Clinical Studies Unit

(904) 953-2255

More information

Publications

Publications are currently not available

Clinical Trials